Drug-induced thrombotic microangiopathy: Experience of the Oklahoma registry and the BloodCenter of Wisconsin

American Journal of Hematology

Volumn 90, Issue 5, 2015, Pages 406-410

  Reese, Jessica A ^a   Bougie, Daniel W ^b   Curtis, Brian R ^b   Terrell, Deirdra R ^a   Vesely, Sara K ^a   Aster, Richard H ^b   George, James N ^a,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIBODY; CAPTOPRIL; CARMUSTINE; CLOPIDOGREL; COCAINE; COTRIMOXAZOLE; CYCLOSPORIN; CYTARABINE; DOCETAXEL; GEMCITABINE; HYDROCHLOROTHIAZIDE; HYDROXYCHLOROQUINE; MITOMYCIN; OXALIPLATIN; PENICILLIN DERIVATIVE; PENTOSTATIN; PRIMIDONE; QUETIAPINE; QUININE; SULFAFURAZOLE; TACROLIMUS; TICLOPIDINE; VANCOMYCIN; DEOXYCYTIDINE; PLATINUM COMPLEX;

ARTICLE; HUMAN; NEUTROPHIL; NEUTROPHIL COUNT; PRIORITY JOURNAL; REGISTER; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNITED STATES; ANALOGS AND DERIVATIVES; BLOOD; CHEMICALLY INDUCED; HEMOLYTIC UREMIC SYNDROME; IMMUNOLOGY; OKLAHOMA; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; WISCONSIN;

AMBULATORY CARE FACILITIES; ANTIBODIES; DEOXYCYTIDINE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; OKLAHOMA; ORGANOPLATINUM COMPOUNDS; PENTOSTATIN; PURPURA, THROMBOTIC THROMBOCYTOPENIC; QUININE; REGISTRIES; THROMBOTIC MICROANGIOPATHIES; VANCOMYCIN; WISCONSIN;

EID: 84928297740     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23960     Document Type: Article

References (22)

1. George JN, Nester CM. Syndromes of thrombotic microangiopathy. New Eng J Med 2014;371:654-666.
2. Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000;356:1255-1259.
3. Al-Nouri ZL, Reese JA, Terrell DR, et al. Drug-induced thrombotic microangiopathy: A systematic review of published reports. Blood 2015;125:616-618.
4. Vesely SK, George JN, Lämmle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;101:60-68.
5. Reese JA, Li X, Hauben M, et al. Identifying drugs that cause acute thrombocytopenia: An analysis using three distinct methods. Blood 2010;116:2127-2133.
6. Bougie D, Aster R. Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Blood 2001;97:3846-3850.
7. Leach JW, Pham T, Diamandidis D, George JN. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T cell lymphoma (sezary syndrome): A case report. Am J Hematol 1999;61:268-270.
8. Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes. Ann Int Med 2001;135:1047-1051.
9. Gottschall JL, Neahring B, McFarl JG, et al. Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: Clinical and serological findings in nine patients and review of literature. Am J Hematol 1994;47:283-289.
10. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Int Med 1998;129:886-890.
11. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Eng J Med 2007;357:580-587.
12. Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired ADAMTS13 deficiency: Comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 2013;60:1676-1682.
13. Saif MW, Xyla V, Makrilia N, et al. Thrombotic microangiopathy associated with gemcitabine: Rare but real. Expert Opin Drug Safety 2009;8:257-260.
14. Moss HK, Herrmann LG. The use of quinine for the relief of "night cramps" in the extremeties. JAMA 1940;115:1358-1359.
15. Brinker AD, Beitz J. Spontaneous reports of thrombocytopenia in association with quinine: Clinical attributes and timing related to regulatory action. Am J Hematol 2002;70:313-317.
16. Kojouri K, Perdue JJ, Medina PJ, George JN. Occult quinine-induced thrombocytopenia. J Okla State Med Assoc 2000;93:519-521.
17. Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: A great imitator. Arch Intern Med 2004;164:218-220.
18. Baliga RS, Wingo CS. Quinine-induced HUS-TTP: An unusual presentation. Am J Med Sci 2003;326:378-380.
19. Spearing RL, Hickton CM, Sizel P, et al. Quinine-induced disseminated intravascular coagulation. Lancet 1990;336:1535-1537.
20. Volcy J, Nzerue CM, Oderinde A, Hewen-Iowe K. Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura. Am J Kidney Dis 2000;35:1-5.
21. Marder E, Kirschke D, Robbins D, et al. Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse-Tennessee, 2012. MMWR 2013;62:1-4.
22. Ambruzs JM, Serrell PB, Rahim N, Larsen CP. Thrombotic microangiopathy and acute kidney injury associated with intravenous abuse of an oral extended-release formulation of oxymorphone hydrochloride: Kidney findings and report of 3 cases. Am J Kidney Dis 2014;63:1022-1026.